Bond.az White LogoBond.az Black Logo

Stifel reiterates IBM Buy after $1bn Chips Act award

Stifel reiterates IBM Buy rating after $1bn Chips Act award for quantum computing. Stock up 15%.

Jack Scott
ByJack Scott- Senior Editor
|
0

Bond.az - Stifel reiterated a Buy rating and $290 price target on IBM following a federal funding announcement for quantum computing development. The stock trades at $252.97, up 15% over the past week, reflecting market enthusiasm.

The U.S. Department of Commerce announced $2 billion from the Chips Act to nine quantum vendors including IBM. IBM will receive $1 billion and invest an additional $1 billion in its quantum foundry, Anderson, which will supply quantum wafers.

The funding aims to keep quantum technology in the U.S. It remains unclear if the government will retain an equity stake. An LOI was signed with final terms to be negotiated in 60-90 days.

Stifel noted that quantum computing and IBM's early lead are gaining traction. Most public quantum companies are small, though Quantinuum, a Honeywell spin-out, recently filed an S-1 and will be a credible comparison.

According to Bond.az analysis, IBM appears undervalued relative to its Fair Value and remains a prominent player in IT Services.

More News
Today / 12:50
|
462

KeyBanc Reiterates Overweight on Walmart, $145 Target

KeyBanc reiterates Overweight on Walmart with $145 target. Walmart shows strong market share gains and digital momentum despite recent stock decline.

0
Today / 12:23
|
531

Cantor Fitzgerald Reiterates Workday Rating on AI Growth

Cantor Fitzgerald reaffirms Workday Overweight rating, highlighting AI growth. Stock at $121.85, target $160.

0
Today / 12:21
|
379

Cantor Reiterates Overweight on ORIC Stock

Cantor Fitzgerald reiterated Overweight on ORIC Pharmaceuticals. Pfizer trial results and analyst ratings update.

0
Today / 12:20
|
278

Summit Therapeutics Analysis: Cantor Fitzgerald Backs Overweight

Cantor Fitzgerald reiterates Overweight on Summit Therapeutics. HARMONi-3 trial miss and analyst views covered by Bond.az.

0
Today / 12:12
|
688

Stifel Maintains Buy on Deckers Outdoor at $140

Stifel reiterates Buy rating on Deckers Outdoor with $140 target. Stock shows strong growth potential and attractive valuation.

0
Today / 12:11
|
286

Argus Upgrades CAVA Group Stock Rating

Argus upgraded CAVA Group to Buy with a $92 target, citing improved restaurant traffic. Stock returned 66% in six months.

0
Today / 12:03
|
516

BofA raises Zoom price target on strong margins

BofA Securities raised Zoom's price target to $105, citing strong margins and free cash flow after Q1 results beat expectations.

0
Today / 11:53
|
249

Workday price target cut by Needham

Needham cuts Workday price target to $180 from $300, maintaining Buy rating. Workday beats revenue and income estimates, raises operating guidance.

0
Today / 11:53
|
473

BioMarin Neutral Rating, $50 Target by HC Wainwright

H.C. Wainwright reiterates Neutral on BioMarin with $50 target after Phase 3 hypochondroplasia results. Stock at $54.10, competitive landscape analyzed.

0
Today / 11:41
|
877

Summit Therapeutics downgraded to neutral

H.C. Wainwright downgrades Summit Therapeutics to Neutral due to competitive pressure from Merck.

0
Today / 11:21
|
610

RBC Capital Initiates Essent Group at Sector Perform

RBC Capital starts Essent Group with Sector Perform, $68 target. Limited earnings growth expected through 2028, with ROE below 12%.

0
Today / 11:02
|
586

Dell Stock Rises on AI Momentum

Evercore ISI reaffirms Dell Outperform on AI momentum. Dell stock up 102% YTD, AI factory serves 5,000+ customers. New products unveiled.

0
...
Stifel reiterates IBM Buy after $1bn Chips Act award | Bond.az